hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.

Exon 11 of the insulin receptor gene (INSR) is alternatively spliced in a developmentally and tissue-specific manner. Linker scanning mutations in a 5' GA-rich enhancer in intron 10 identified AGGGA sequences that are important for enhancer function. Using RNA-affinity purification and mass spe...

Full description

Bibliographic Details
Main Authors: Indrani Talukdar, Supriya Sen, Rodolfo Urbano, James Thompson, John R Yates, Nicholas J G Webster
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3223206?pdf=render
id doaj-76126059c4984455833b50e99812271f
record_format Article
spelling doaj-76126059c4984455833b50e99812271f2020-11-25T01:56:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01611e2786910.1371/journal.pone.0027869hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.Indrani TalukdarSupriya SenRodolfo UrbanoJames ThompsonJohn R YatesNicholas J G WebsterExon 11 of the insulin receptor gene (INSR) is alternatively spliced in a developmentally and tissue-specific manner. Linker scanning mutations in a 5' GA-rich enhancer in intron 10 identified AGGGA sequences that are important for enhancer function. Using RNA-affinity purification and mass spectrometry, we identified hnRNP F and hnRNP A1 binding to these AGGGA sites and also to similar motifs at the 3' end of the intron. The hnRNPs have opposite functional effects with hnRNP F promoting and hnRNP A1 inhibiting exon 11 inclusion, and deletion of the GA-rich elements eliminates both effects. We also observed specific binding of hnRNP A1 to the 5' splice site of intron 11. The SR protein SRSF1 (SF2/ASF) co-purified on the GA-rich enhancer and, interestingly, also competes with hnRNP A1 for binding to the splice site. A point mutation -3U→C decreases hnRNP A1 binding, increases SRSF1 binding and renders the exon constitutive. Lastly, our data point to a functional interaction between hnRNP F and SRSF1 as a mutant that eliminates SRSF1 binding to exon 11, or a SRSF1 knockdown, which prevents the stimulatory effect of hnRNP F over expression.http://europepmc.org/articles/PMC3223206?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Indrani Talukdar
Supriya Sen
Rodolfo Urbano
James Thompson
John R Yates
Nicholas J G Webster
spellingShingle Indrani Talukdar
Supriya Sen
Rodolfo Urbano
James Thompson
John R Yates
Nicholas J G Webster
hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
PLoS ONE
author_facet Indrani Talukdar
Supriya Sen
Rodolfo Urbano
James Thompson
John R Yates
Nicholas J G Webster
author_sort Indrani Talukdar
title hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
title_short hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
title_full hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
title_fullStr hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
title_full_unstemmed hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
title_sort hnrnp a1 and hnrnp f modulate the alternative splicing of exon 11 of the insulin receptor gene.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description Exon 11 of the insulin receptor gene (INSR) is alternatively spliced in a developmentally and tissue-specific manner. Linker scanning mutations in a 5' GA-rich enhancer in intron 10 identified AGGGA sequences that are important for enhancer function. Using RNA-affinity purification and mass spectrometry, we identified hnRNP F and hnRNP A1 binding to these AGGGA sites and also to similar motifs at the 3' end of the intron. The hnRNPs have opposite functional effects with hnRNP F promoting and hnRNP A1 inhibiting exon 11 inclusion, and deletion of the GA-rich elements eliminates both effects. We also observed specific binding of hnRNP A1 to the 5' splice site of intron 11. The SR protein SRSF1 (SF2/ASF) co-purified on the GA-rich enhancer and, interestingly, also competes with hnRNP A1 for binding to the splice site. A point mutation -3U→C decreases hnRNP A1 binding, increases SRSF1 binding and renders the exon constitutive. Lastly, our data point to a functional interaction between hnRNP F and SRSF1 as a mutant that eliminates SRSF1 binding to exon 11, or a SRSF1 knockdown, which prevents the stimulatory effect of hnRNP F over expression.
url http://europepmc.org/articles/PMC3223206?pdf=render
work_keys_str_mv AT indranitalukdar hnrnpa1andhnrnpfmodulatethealternativesplicingofexon11oftheinsulinreceptorgene
AT supriyasen hnrnpa1andhnrnpfmodulatethealternativesplicingofexon11oftheinsulinreceptorgene
AT rodolfourbano hnrnpa1andhnrnpfmodulatethealternativesplicingofexon11oftheinsulinreceptorgene
AT jamesthompson hnrnpa1andhnrnpfmodulatethealternativesplicingofexon11oftheinsulinreceptorgene
AT johnryates hnrnpa1andhnrnpfmodulatethealternativesplicingofexon11oftheinsulinreceptorgene
AT nicholasjgwebster hnrnpa1andhnrnpfmodulatethealternativesplicingofexon11oftheinsulinreceptorgene
_version_ 1724981857944076288